Advertisement

Topics

AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides

14:00 EST 13 Nov 2018 | Drugs.com

TUESDAY, Nov. 13, 2018 -- Icosapent ethyl is associated with a reduced risk for ischemic events among patients with elevated triglyceride levels despite taking statins, according to a study published online Nov. 10 in the New England Journal of...

Original Article: AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides

NEXT ARTICLE

More From BioPortfolio on "AHA: Icosapent Ethyl Cuts CV Risk From Elevated Triglycerides"

Advertisement
Quick Search
Advertisement
Advertisement